1. Home
  2. CVM vs SRL Comparison

CVM vs SRL Comparison

Compare CVM & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • SRL
  • Stock Information
  • Founded
  • CVM 1983
  • SRL 2017
  • Country
  • CVM United States
  • SRL China
  • Employees
  • CVM N/A
  • SRL N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • SRL Professional Services
  • Sector
  • CVM Health Care
  • SRL Consumer Discretionary
  • Exchange
  • CVM Nasdaq
  • SRL Nasdaq
  • Market Cap
  • CVM 71.2M
  • SRL 81.5M
  • IPO Year
  • CVM 1987
  • SRL N/A
  • Fundamental
  • Price
  • CVM $10.03
  • SRL $5.14
  • Analyst Decision
  • CVM
  • SRL
  • Analyst Count
  • CVM 0
  • SRL 0
  • Target Price
  • CVM N/A
  • SRL N/A
  • AVG Volume (30 Days)
  • CVM 303.9K
  • SRL 2.0K
  • Earning Date
  • CVM 08-14-2025
  • SRL 04-30-2025
  • Dividend Yield
  • CVM N/A
  • SRL 20.23%
  • EPS Growth
  • CVM N/A
  • SRL N/A
  • EPS
  • CVM N/A
  • SRL N/A
  • Revenue
  • CVM N/A
  • SRL $24,535,042.00
  • Revenue This Year
  • CVM N/A
  • SRL N/A
  • Revenue Next Year
  • CVM N/A
  • SRL N/A
  • P/E Ratio
  • CVM N/A
  • SRL N/A
  • Revenue Growth
  • CVM N/A
  • SRL N/A
  • 52 Week Low
  • CVM $1.98
  • SRL $5.13
  • 52 Week High
  • CVM $39.30
  • SRL $9.99
  • Technical
  • Relative Strength Index (RSI)
  • CVM 52.57
  • SRL 41.49
  • Support Level
  • CVM $9.58
  • SRL $5.22
  • Resistance Level
  • CVM $12.68
  • SRL $5.50
  • Average True Range (ATR)
  • CVM 1.30
  • SRL 0.14
  • MACD
  • CVM -0.28
  • SRL 0.01
  • Stochastic Oscillator
  • CVM 28.57
  • SRL 1.82

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: